Additionally, Cav1 inhibits the Ras-MAPK/ERK pathway and PI3K/AKT pathways, both frequently activated in cancer cells to promote survival and proliferation (Cohen et al., 2004; Engelman et al., 1998; Matthews et al., 2008). Here, CAV1 is linked to cancer.